Metabolic Homeostasis Disturbances in Patients with Pulmonary Tuberculosis and Type 2 Diabetes Mellitus: A Comparative Clinical Study
Tuberculosis, Lung Diseases, HIV Infection · 06.11.2026 · (4) · 33-39
DOI: 10.30978/tb2026-4-33 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tuberculosis, Lung Diseases, HIV Infection, online erschienen am 06.11.2026. Verfasst von I. Semianiv. Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
The coexistence of pulmonary tuberculosis (TB) and type 2 diabetes mellitus (T2DM) represents one of the most important challenges in modern phthisiology and endocrinology, as it is associated with mutual aggravation of disease progression, disturbances of metabolic homeostasis, systemic inflammation, and poorer treatment outcomes. Despite considerable scientific interest in this comorbidity, the relationships between protein metabolism, carbohydrate metabolism, coagulation-fibrinolytic activity, and clinical manifestations remain insufficiently studied. Objective — to assess the state of selected components of metabolic homeostasis in patients with pulmonary tuberculosis combined with type 2 diabetes mellitus and to determine their relationship with clinical manifestations of the disease. Materials and methods. A comparative clinical and laboratory study included 100 participants divided into four groups: patients with pulmonary TB and T2DM (n = 30), patients with pulmonary TB without diabetes (n = 30), patients with T2DM without TB (n = 30), and apparently healthy individuals (n = 10). Protein metabolism parameters (total protein, albumin), coagulation-fibrinolytic markers (fibrinogen, prothrombin time), carbohydrate metabolism indicators (glucose, HbA1c, insulin, C-peptide), and C-reactive protein levels were analysed. Parametric and non-parametric statistical methods were applied for intergroup comparisons, as well as correlation analysis using Pearson, Spearman, and Kendall coefficients. Results and discussion. Patients with combined TB/T2DM demonstrated the most pronounced metabolic disturbances. Total protein level was (53.6 ± 1.23) g/L, significantly lower than in all other groups (p < 0.05). More severe hypoalbuminaemia, elevated levels of C-reactive protein, fibrinogen, creatinine, and uric acid were observed. Mean blood glucose concentration in the TB/T2DM group reached (9.44 ± 2.23) mmol/L, while HbA1c values were significantly higher than those in the other study groups (p < 0.001). A decrease in C-peptide levels compared with patients with isolated T2DM indicated partial exhaustion of pancreatic β-cell compensatory capacity. The strongest correlations with clinical symptom severity were identified for total protein (r = –0.805), C-reactive protein (r = +0.673), uric acid (r = +0.402), and C-peptide (r = +0.320). Conclusions. The coexistence of pulmonary TB and T2DM is associated with the development of a distinct metabolic phenotype characterised by significant disturbances in protein and carbohydrate metabolism, activation of systemic inflammation, and alterations in coagulation-fibrinolytic homeostasis. Hypoproteinaemia and systemic inflammatory response appear to have the greatest impact on clinical disease severity. These findings support the importance of comprehensive monitoring of metabolic parameters in patients with TB/T2DM for disease severity assessment and individualised treatment strategies.
Zitieren
APA
Semianiv, I. (2026). Metabolic Homeostasis Disturbances in Patients with Pulmonary Tuberculosis and Type 2 Diabetes Mellitus: A Comparative Clinical Study. Tuberculosis, Lung Diseases, HIV Infection, 33-39. https://doi.org/10.30978/tb2026-4-33
Vancouver
Semianiv I. Metabolic Homeostasis Disturbances in Patients with Pulmonary Tuberculosis and Type 2 Diabetes Mellitus: A Comparative Clinical Study. Tuberculosis, Lung Diseases, HIV Infection. 2026:33-39. doi:10.30978/tb2026-4-33
BibTeX
@article{Semianiv2026,
author = {Semianiv, I.},
title = {Metabolic Homeostasis Disturbances in Patients with Pulmonary Tuberculosis and Type 2 Diabetes Mellitus: A Comparative Clinical Study},
journal = {Tuberculosis, Lung Diseases, HIV Infection},
year = {2026},
number = {4},
pages = {33--39},
doi = {10.30978/tb2026-4-33}
}
EUVIMED